Phase 3 data shows approximately 22-25% weight loss, making it competitive with retatrutide through a completely different mechanism
Clarify how often you will need follow-up visits, lab tests, or monitoring while on tirzepatide to ensure your safety throughout the treatment
Retatrutide and Tirzepatide: Retatrutide and Tirzepatide are newer additions to the GLP-1 analogue family and are currently under investigation in clinical trials for obesity treatment
Maximum savings reduced from $225 to $100 per fill, with minimum copay now $25/month
Wegovy also comes as a daily pill for $299 monthly, making it ideal for those who dont do needles
The follow-up time for each individual was divided into three time periods: (1) pretreatment (12 months before initiation), (2) initial exposed period (0-12 months), and (3) late exposed period (13-24 months)